|
 |
|
|||||||
|
|||||||||
Copyright ©ERS Journals Ltd 2007
COPD prevalence in a random population survey: a matter of definition
1 Medical Research Institute of New Zealand, and 2 Wellington School of Medicine and Health Sciences, Wellington, New Zealand, 3 Imperial College, and 4 GlaxoSmithKline, London, and 5 University of Southampton, Southampton, UK.
CORRESPONDENCE: R. Beasley, Medical Research Institute of New Zealand, P.O. Box 10055, Wellington, New Zealand. Fax: 64 44729224. E-mail: Richard.Beasley{at}mrinz.ac.nz
Keywords: Chronic obstructive pulmonary disease, lower limit of normal, prevalence
Received: December 4, 2006
Accepted March 6, 2007
A recent American Thoracic Society and European Respiratory Society joint Task Force report recommends using a lower limit of normal (LLN) of forced expiratory volume in one second/forced vital capacity as opposed to a fixed ratio of <0.7 to diagnose airflow obstruction, in order to reduce false positive diagnoses of chronic obstructive pulmonary disease (COPD) as defined by the Global Initiative for Obstructive Lung Disease (GOLD). To date, there is no reliable spirometry-based prevalence data for COPD in New Zealand and the effect of different definitions of airflow obstruction based on post-bronchodilator spirometry is not known.
Detailed written questionnaires, full pulmonary function tests (including pre- and post-bronchodilator flow–volume loops) and atopy testing were completed in 749 subjects recruited from a random population sample.
The GOLD-defined, age-adjusted prevalence (95% confidence interval) for adults aged
The prevalence of chronic obstructive pulmonary disease varied markedly depending on the definition used. Further research using longitudinal rather than cross-sectional data will help decide the preferred approach in chronic obstructive pulmonary disease prevalence surveys.
40 yrs was 14.2 (11.0–17.0)% compared with an LLN-defined, age-adjusted, post-bronchodilator prevalence in the same group of 9.0 (6.7–11.3)%.
This article has been cited by other articles:
|
|
 |
|
  M. Weatherall, S. Marsh, P. Shirtcliffe, M. Williams, J. Travers, and R. Beasley Quality of life measured by the St George's Respiratory Questionnaire and spirometry Eur. Respir. J., May 1, 2009; 33(5): 1025 - 1030. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. N. Methvin, D. M. Mannino, and B. R. Casey COPD Prevalence in Southeastern Kentucky: The Burden of Lung Disease Study Chest, January 1, 2009; 135(1): 102 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. W. S. Ko, J. Woo, W. Tam, C. K. W. Lai, J. Ngai, T. Kwok, and D. S. C. Hui Prevalence and risk factors of airflow obstruction in an elderly Chinese population Eur. Respir. J., December 1, 2008; 32(6): 1472 - 1478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I Cerveri, A G Corsico, S Accordini, R Niniano, E Ansaldo, J M Anto, N Kunzli, C Janson, J Sunyer, D Jarvis, et al. Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes Thorax, December 1, 2008; 63(12): 1040 - 1045. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M P Swanney, G Ruppel, P L Enright, O F Pedersen, R O Crapo, M R Miller, R L Jensen, E Falaschetti, J P Schouten, J L Hankinson, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction Thorax, December 1, 2008; 63(12): 1046 - 1051. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. R. J. Schermer, I. J. M. Smeele, B. P. A. Thoonen, A. E. M. Lucas, J. G. Grootens, T. J. van Boxem, Y. F. Heijdra, and C. van Weel Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care Eur. Respir. J., October 1, 2008; 32(4): 945 - 952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S E Marsh, J Travers, M Weatherall, M V Williams, S Aldington, P M Shirtcliffe, A L Hansell, M R Nowitz, A A McNaughton, J B Soriano, et al. Proportional classifications of COPD phenotypes Thorax, September 1, 2008; 63(9): 761 - 767. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P-O Bridevaux, M W Gerbase, N M Probst-Hensch, C Schindler, J-M Gaspoz, and T Rochat Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD Thorax, September 1, 2008; 63(9): 768 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. MacNee Update in Chronic Obstructive Pulmonary Disease 2007 Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 820 - 829. [Full Text] [PDF]
|
|
|
|
|
|
M. R. Sears Population prevalence of COPD Eur. Respir. J., January 1, 2008; 31(1): 218 - 218. [Full Text] [PDF]
|
|
|
|
|
|
P. Shirtcliffe, M. Weatherall, and R. Beasley From the authors Eur. Respir. J., January 1, 2008; 31(1): 218 - 219. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |